TL;DR: Aetna modified CPB 0680 governing electrical stimulation for chronic ulcers, effective January 5, 2026. Billing teams using CPT 97014, 97032, and HCPCS G0281 need to confirm they're meeting updated adjunctive therapy and healing-progress criteria before submitting claims.
Aetna's electrical stimulation coverage policy under CPB 0680 applies to arterial ulcers, diabetic ulcers, Stage III and IV pressure ulcers, and venous stasis ulcers. The policy draws hard lines around treatment duration, home-use settings, and what counts as adequate conventional wound care before electrical stimulation can begin. If your team bills these services for Aetna members, the criteria are tighter than they may look at first read.
| Field | Detail |
|---|---|
| Payer | Aetna |
| Policy | Electrical Stimulation for Chronic Ulcers |
| Policy Code | CPB 0680 |
| Change Type | Modified |
| Effective Date | January 5, 2026 |
| Impact Level | High |
| Specialties Affected | Wound care, physical therapy, podiatry, vascular surgery, DME suppliers |
| Key Action | Audit active claims for CPT 97014, 97032, and HCPCS G0281 against the 30-day conventional treatment requirement and 60-minute daily cap before billing |
Aetna Electrical Stimulation for Chronic Ulcers Coverage Criteria and Medical Necessity Requirements 2026
Aetna classifies electrical stimulation for chronic ulcers as medically necessary durable medical equipment (DME) — but only after a 30-day window of conventional wound treatment with no measurable healing. That's the threshold your documentation has to clear before any claim for CPT 97014 (electrical stimulation, unattended) or CPT 97032 (electrical stimulation, manual, each 15 minutes) will hold up.
The four qualifying ulcer types are arterial ulcers, diabetic ulcers, Stage III or Stage IV pressure ulcers, and venous stasis ulcers. Stage III means the defect extends into muscle. Stage IV means it reaches bone or joint. Anything shallower than Stage III for pressure ulcers doesn't qualify under this coverage policy.
Conventional wound treatment isn't loosely defined here. Aetna's policy specifies nutritional optimization, debridement by any means to remove devitalized tissue, moist wound dressings, and infection management. For pressure ulcers, that includes repositioning at least every two hours. For diabetic ulcers, it includes off-loading and glucose control. For arterial ulcers, adequate circulation must be established. For venous ulcers, a compression system is required. Your documentation has to show all of this happened for 30 days before electrical stimulation began — otherwise the claim is experimental by Aetna's definition.
On duration: the policy caps treatment at 60 minutes per day. Anything beyond one hour per day is not considered medically necessary. A typical course runs no more than four weeks. If the wound shows no measurable healing within that four-week window — defined as a decrease in wound surface area or volume, reduced exudate, or reduced necrotic tissue — continued electrical stimulation is not covered.
Coverage also ends automatically once the wound reaches 100% epithelialization. Bill HCPCS G0281 for unattended electrical stimulation at Stage III and IV pressure ulcers. The distinction between G0281 and other electrical stimulation HCPCS codes matters — using the wrong code for the ulcer stage is a fast path to a claim denial. Verify the covered HCPCS code for your specific non-pressure ulcer wound type directly against the full CPB 0680 policy before submitting.
One more hard line in this coverage policy: electrical stimulation for chronic ulcers in the home setting is not medically appropriate under CPB 0680. Full stop. If your DME supplier is billing for home-use electrical stimulation units for wound care, that reimbursement is at risk.
Aetna Electrical Stimulation Exclusions and Non-Covered Indications
Several applications of electrical stimulation carry an experimental, investigational, or unproven designation under this policy. These aren't gray areas — Aetna has explicitly listed them, and billing for them under covered codes is a liability.
Not covered under any indication:
| # | Excluded Procedure |
|---|---|
| 1 | Neuromuscular electrical stimulation (HCPCS E0745) as adjunctive therapy for diabetic foot ulcers |
| 2 | Combined electrical stimulation and fibrin glue (HCPCS C9250) for decubitus ulcers |
| 3 | Combined modulated ultrasound (CPT 97035) and electrical current stimulation for diabetic foot ulcers |
| 4 | Prevention of ulcers or pressure sores |
| 5 | Treatment of infected wounds |
| 6 | Frequency rhythmic electrical modulation and wireless micro-current stimulation |
| 7 | Microcurrent as adjunctive therapy for chronic wound healing |
| 8 | VeinoPlus device for venous ulcers (no specific HCPCS code assigned under this policy) |
If your practice uses microcurrent devices or the VeinoPlus system, stop billing those under electrical stimulation codes for Aetna members now. There's no path to coverage for these under CPB 0680 in its current form.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Arterial ulcers (after 30 days of conventional treatment, no healing) | Covered | CPT 97014, 97032 | Must document adequate circulation establishment; verify applicable HCPCS code against full policy |
| Diabetic ulcers (after 30 days, no healing) | Covered | CPT 97014, 97032 | Off-loading and glucose control documentation required; verify applicable HCPCS code against full policy |
| Stage III pressure ulcers (after 30 days, no healing) | Covered | CPT 97014, 97032; G0281 | Repositioning q2h documentation required |
| Stage IV pressure ulcers (after 30 days, no healing) | Covered | CPT 97014, 97032; G0281 | Repositioning q2h documentation required |
| Venous stasis ulcers (after 30 days, no healing) | Covered | CPT 97014, 97032 | Compression system use must be documented; verify applicable HCPCS code against full policy |
| Electrical stimulation in home setting | Not Covered | — | Explicitly excluded regardless of ulcer type |
| Electrical stimulation beyond 60 min/day | Not Covered | — | No clinical evidence of added benefit |
| Continued treatment after 100% epithelialization | Not Covered | — | Coverage ends at wound closure |
| Continued treatment with no healing at 4 weeks | Not Covered | — | Measurable healing required to continue |
| Neuromuscular electrical stimulation for diabetic foot ulcers | Experimental | E0745 | Not covered under any circumstance |
| Electrical stimulation + fibrin glue for decubitus ulcers | Experimental | C9250 | Combination use excluded |
| Modulated ultrasound + electrical stimulation for diabetic foot ulcers | Experimental | CPT 97035 | Ultrasound code explicitly not covered |
| Microcurrent therapy for chronic wound healing | Experimental | — | No specific code; billed under various codes |
| VeinoPlus device for venous ulcers | Experimental | — | No specific HCPCS code assigned under CPB 0680 |
| Ulcer or pressure sore prevention | Experimental | — | Not a covered indication |
| Treatment of infected wounds | Experimental | — | Excluded regardless of wound type |
| Frequency rhythmic / wireless micro-current stimulation | Experimental | — | Explicitly excluded |
Aetna Electrical Stimulation Billing Guidelines and Action Items 2026
The effective date is January 5, 2026. If you're already billing these services, assume this policy is in force now.
| # | Action Item |
|---|---|
| 1 | Audit your active electrical stimulation claims for Aetna members today. Pull any open claims using CPT 97014, 97032, and G0281. Confirm each has a documented 30-day conventional wound care period with no measurable healing before electrical stimulation started. |
| 2 | Verify ulcer staging before submitting G0281 for pressure ulcers. G0281 is for Stage III and Stage IV pressure ulcers specifically. For other qualifying ulcer types, verify the correct HCPCS code directly against the full CPB 0680 policy before billing. Using the wrong code for the ulcer stage is a common source of claim denial — review your charge capture templates. |
| 3 | Build a daily time cap into your documentation workflow. Treatment exceeding 60 minutes per day is automatically not medically necessary. If your wound care team is running longer sessions, that has to stop before those claims go out. Document time per session on every encounter. |
| 4 | Stop billing home-use electrical stimulation for wound care under any Aetna plan. CPB 0680 explicitly excludes the home setting. If your DME supplier has been billing any electrical stimulation code for home wound care, pull those claims and assess your exposure. Talk to your compliance officer if you haven't already. |
| 5 | Set a 4-week reassessment checkpoint for every active case. If the wound hasn't shown measurable improvement by week four — smaller surface area, reduced exudate, or less necrotic tissue — continued electrical stimulation isn't billable. Build that checkpoint into your clinical workflow so it doesn't get missed. |
| 6 | Remove C9250 and CPT 97035 from your electrical stimulation billing order sets for Aetna. These codes are either explicitly experimental or excluded under CPB 0680. Billing them on wound care claims invites denial and potential audit exposure. |
| 7 | Confirm prior authorization requirements with each specific Aetna plan. CPB 0680 does not address prior authorization at the policy level. Individual Aetna plan contracts may layer on prior auth for DME and therapy codes. This is standard billing practice — confirm prior auth status with the plan before starting treatment. |
If your practice has a complex mix of wound care patients across multiple Aetna product lines, loop in your compliance officer before making blanket changes to your billing guidelines. The home-setting exclusion and the 4-week no-healing cutoff carry real financial exposure if claims are already in flight.
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Electrical Stimulation for Chronic Ulcers Under CPB 0680
Covered CPT Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| 97014 | CPT | Application of a modality to one or more areas; electrical stimulation (unattended) |
| 97032 | CPT | Application of a modality to one or more areas; electrical stimulation (manual), each 15 minutes |
Not Covered / Experimental Codes
| Code | Type | Description | Reason |
|---|---|---|---|
| 97035 | CPT | Application of a modality to 1 or more areas; ultrasound, each 15 minutes (modulated ultrasound) | Not covered for indications listed in CPB 0680 |
| E0745 | HCPCS | Neuromuscular stimulator, electronic shock unit | Experimental for neuromuscular electrical stimulation for diabetic foot ulcers |
| C9250 | HCPCS | Human plasma fibrin sealant, vapor-heated, solvent-detergent (Artiss), 2 ml | Experimental when combined with electrical stimulation for decubitus ulcers |
Covered HCPCS Codes (When Selection Criteria Are Met)
| Code | Type | Description |
|---|---|---|
| G0281 | HCPCS | Electrical stimulation (unattended), to one or more areas, for chronic Stage III and Stage IV pressure ulcers |
Key ICD-10-CM Diagnosis Codes
| Code | Description |
|---|---|
| E08.621 | Diabetes mellitus due to underlying condition with foot ulcer |
| E08.622 | Diabetes mellitus due to underlying condition with other skin ulcer |
| E09.621 | Drug or chemical induced diabetes mellitus with foot ulcer |
| E09.622 | Drug or chemical induced diabetes mellitus with other skin ulcer |
| E10.621 | Type 1 diabetes mellitus with foot ulcer |
| E10.622 | Type 1 diabetes mellitus with other skin ulcer |
| E11.621 | Type 2 diabetes mellitus with foot ulcer |
| E11.622 | Type 2 diabetes mellitus with other skin ulcer |
| E13.621–E13.622 | Other specified diabetes mellitus with ulcer |
| I74.2 | Embolism and thrombosis of arteries of the upper extremities (arterial ulcers) |
| I74.3 | Embolism and thrombosis of arteries of the lower extremities (arterial ulcers) |
| I74.5 | Embolism and thrombosis of iliac artery (arterial ulcers) |
| I77.89 | Other specified disorders of arteries and arterioles (arterial ulcers) |
| I83.1 | Varicose veins of lower extremities with ulcer |
| I83.10–I83.19 | Varicose veins of lower extremities with ulcer, various sites |
| I83.20–I83.29 | Varicose veins of lower extremities with ulcer and inflammation, various sites |
| I83.201–I83.229 | Varicose veins of lower extremities with ulcer and inflammation, specific sites |
Note: The full ICD-10-CM code set under CPB 0680 includes 179 codes. The codes above represent the primary diagnostic categories. Review the full code list at the CPB 0680 policy source before updating your superbills.
Get the Full Picture for CPT 97014
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.